Castleman Disease is a lymphoid disorder characterized by the presence of an enlarged or abnormal lymph node/lymphatic tissue. The disease is classified into unicentric or multicentric variants. The unicentric form is a benign disorder that is usually asymptomatic and consists of a single lymphoid mass that is predominantly located in the mediastinum, but can also rarely develop in the neck or abdomen. The multicentric type involves more than one lymphatic station and is related to the presence of type B symptoms (fevers, night sweats and weight loss), HIV/HHV8 infection and increased serum IL-6 levels. We present the case of an unusual pelvic intraperitoneal manifestation of Castleman Disease in a 52-year-old caucasian woman who showed clinical, radiological, histological and laboratory findings common to both Unicentric and Multicentric Castleman Disease.
A contrast-enhanced abdominal computed tomography (CT) examination was performed shortly after at our Institution and revealed a right-pelvis centered 4.7 cm sized intraperitoneal solid mass (113 HU after contrast administration), with regular but lobulated margins and several intralesional punctate calcifications; an isolated enlarged right obturator lymph node was documented as well (maximum diameter of 26 mm) (Fig. 3, Fig. 4 ).
Due to shape, location and unknown nature of the described mass, the patient underwent a whole-body 18 F-FDG positron emission tomography (PET) that showed a moderate hypermetabolic activity (SUVmax 5) of both the ovarian lesion and of the enlarged ipsilateral obturator lymph node (Fig. 5,  Fig. 6 ).
As a consequence, the patient underwent an explorative laparoscopic surgery at our Institution, in which the intraperitoneal mass was excised.
CASE REPORT
At histologic examination the mass presented as a lymph node with peculiar features: several B-cell (CD20+, CD79a+) lymphoid follicles were found, with a variable histologic appearance, the majority showing regressively transformed B cell lymphomas-2 (Bcl-2) negative germinal centers, mainly consisting of follicular dendritic cells (CD21+, CD23+), with an expanded mantle region around and a hypervascular interfollicular zone (Fig. 7 a, b, d ). The mantle cells formed concentric rings around FDCs (onion skin pattern). Some vascular hyalinized vessels radially penetrated into the germinal center to form the characteristic "lollipop" follicles ( Fig. 7 b) . The interfollicolar area contained increased number of high endothelial venules and small CD3+ T-cell lymphocytes. The immunohistochemical staining for HHV8-related proteins was unremarkable. On the base of such findings, a histopathological diagnosis of hyaline-vascular type Castleman Disease (CD) was suggested. Once the histopathological diagnosis was confirmed, a blood panel performed revealed a mild reduction of WBC (2550/mm 3 ) with neutropenia (1700/mm 3 ) and lymphopenia (500/mm 3 ), a mild increase of light chain K and in K/λ rate (2.1), normal levels of LDH and β2 microglobulin. Immunostaining and urine exam were unremarkable, nonetheless a mild increase in serum level of IL-6 was detected. Serologies for HIV, HCV, HBV and HHV8 were unremarkable.
These finding were unable to fully confirm the supposed diagnosis of Unicentric Castleman Disease; in fact, even if virology was negative for a forementioned viruses and histological finding of hyaline-vascular pattern is commonly linked to this variant of Castleman disease, the presence of two pathological masses and the increase of IL-6 serum levels supported the theory of a Multicentric Castleman Disease (MCD). Two months later another follow-up CT examination was performed, demonstrating no recurrence of the mass (Fig.  8 a) , and the persistence of the enlarged right obturator lymph node (Fig. 8 b) , though it did not show a hypermetabolic activity at another 18 F-FDG-PET examination (Fig. 9 ). Moreover the patient did not complain about pelvic pain.
The patient is still in clinical, radiological and laboratory follow-up, with no evidence of recurrent disease.
The presented case report revealed characteristics common to both Unicentric and Multicentric Castleman Disease: the patient did not show typical B symptoms (fevers, night sweats and weight loss), yet with laboratory indices impairment, especially of IL-6 levels. A CT scans demonstrated two pathological pelvic lesions: the largest being a right pelvic mass, yet with histology consistent for Hyaline Vascular-Castleman Disease and negative HHV8 immunostaining, the other an enlarged ipsilateral obturator lymph node.
A short-term post-operative follow up CT performed two months after the surgical removal of the larger mass confirmed the persistence of the enlarged obturator lymph node, but with no pathologic metabolic activity at PET. Moreover IL-6 serum level had got back into the normal range and the patient referred to get healthy. As a consequence, the diagnosis of Unicentric Castleman disease was achieved.
Etiology & Demographics:
Castleman Disease (CD), also known as angiofollicular lymph node hyperplasia, was described for the first time in 1956, when Benjamin Castleman reported a series of 13 subjects with localized enlargement of mediastinal hypervascular lymph nodes
Castleman Disease is a rare benign lymphoid disorder with a heterogeneous clinical presentation and unknown etiology, and is classified into two main different forms. The most frequent Unicentric form, (incidence of 16 cases/million person years [4] ) is commonly diagnosed in the third or fourth decade of life and shows a modest female predominance [5] , whereas the Multicentric form has an estimated incidence of 5 cases/million person years [4] and typically occurs in older subjects, usually around their sixth decade, with a slightly higher prevalence in males [5] . A third form of Castleman Disease, described as a variant of Multicentric Castleman Disease and linked to HHV8 co-infection, was recently defined, showing a variable incidence and mostly affecting HIV seropositive males [4] .
Clinical & Imaging findings:
Castleman Disease can be clinically and radiologically divided into two different forms: the Unicentric form (UCD) which is usually asymptomatic, and the Multicentric form (MCD) which has a higher rate of systemic manifestations and shows increased serum IL-6 levels and a worse prognosis UCD is usually asymptomatic at the time of diagnosis and is usually discovered at radiological examinations performed for other reasons. It is more commonly detected in the chest (30%), whereas several cases have been reported in the neck (23%), abdomen (20%), retroperitoneum (17%) and rarely in the axilla (5%), the groin (3%) and the pelvis (2%) [3] .
Both MRI and CT are used to evaluate the CD lymphoid masses, but a definitive diagnosis of Castleman Disease is usually based on the histopathological examination [7] [10].
The abdominal and pelvic localizations of HV-CD (the presented case and also the most common variant) are commonly characterized at CT imaging by a single, well defined, homogeneous soft-tissue attenuation mass with marked or moderate enhancement after contrast administration. Masses larger than 5 cm in their maximum diameter can additionally show central low attenuation due to central fibrosis or necrosis. Intralesional calcifications occur in 30% of cases [11] . A peripheral rim-like enhancement of the mass, especially evident in the arterial phase, or a local peritoneal thickening around the main mass can also be found [12] .
At MRI, pelvic Unicentric Castleman Disease lesions typically appear as hypointense on T1-weighted images and hyperintense on T2-weighted images, but such characteristics are unspecific [7] .
Whole-body PET has a role to assess the metabolic status of masses/enlarged lymph nodes suspected for CD.
18 F-FDG-PET allows the recognition of high metabolic uptakes even in non-enlarged lymph nodes, thus playing a role in both staging and monitoring of the disease [8] .
Laboratory abnormalities, like anemia and elevation of inflammatory markers, or the presence of type B symptoms (fevers, night sweats and weight loss) are extremely rare in UCD, but can be more frequently observed in histologically proven PC-CD [3], which occurs in only few UCD cases (9-24% of the total) [6].
MCD represent the "dark side" of Castleman disease. HIV infection is an important risk and bad prognosis factor, but all HIV positive patients develop the MCD are co-infected with HHV8. HHV8 can also affect HIV negative patients, and is present in 50% cases of MCD arising in HIV negative patients. The remaining 50% of MCDs have histopathological feature consistent with the PC-CD variant [3].
The majority of MCD patients present with type B symptoms, multiple lymphadenopathies, hepatosplenomegaly and fluid retention within the third space. Laboratory abnormalities, such as the increase of inflammatory markers and more specifically of cytokine levels (IL-6 above all) are common in these patients [3] .
At imaging, multiple lymphadenopathies are commonly found in MCD. HV-CD and PC-CD show different CT enhancement patterns, respectively more prominent for HV-CD and less relevant for PC-CD. Such finding, however, is not sufficient to distinguish between the histologic subtypes [13] .
Treatment & Prognosis:
Patients with UCD have nearly 100%-5-year survival following en bloc surgical resection [7] ; patients unsuitable for surgery can undergo radiation therapy [3] . The surgical removal of the lymphoid tissue eliminates the clinical symptoms, if present, and reduces IL-6 serum levels [14] .
Due to the risk of lymphomatous conversion of the lymphoid masses and to the possibility of developing a lymphoma in other sites, a post-surgical clinical-radiological surveillance is recommended. The follow-up of these patients should therefore include an annual 18 F-FDG-PETand serum biomarkers (IL-6, CRP, serum free light chains, and quantitative immunoglobulins) [8] .
Treatment of MCD is based on corticosteroid, chemotherapy, monoclonal antibodies and radiotherapy and, in certain cases, on combined therapy; MCD, however, is difficult to be treated and completely eradicated [3] [7] .
Differential Diagnosis: UCD shows unspecific imaging features. At CT examination UCD can be described as a single, well-defined mass with homogeneous soft-tissue attenuation marked or moderated enhancement in the post-contrast arterial phase and punctate calcifications. At MRI examination, UCD characteristics include T1-hypointensity, T2 hyperintensity and contrast enhancement after gadolinium administration.
The differential diagnosis for abdominal-pelvic UCD include lymphomas, retroperitoneal sarcoma, desmoid tumors [8] and metastatic disease.
Conversely, differential diagnosis of MCD includes lymphomas, infections and immunological diseases like systemic lupus erythematosus (SLE); in HIV seropositive subjects, also persistent generalized lymphadenopathies (PGL) should be taken into account as a mimicker [2].
Whole body PET demonstrates an elevated glucose uptake in both enlarged and in non-enlarged nodes but generally, in CD masses, FDG uptake is less prominent than what is observed in lymphomas [2].
In conclusion, when a single, well-defined, homogeneous soft-tissue attenuation abdominal-pelvic mass or a single enlarged lymph node with marked or moderate enhancement is detected at CT examination, Unicentric Castleman disease should be included in the differential diagnosis and an excisional biopsy should be performed for confirmation.
Unicentric Castleman disease (UCD) should be considered when a single, well defined, homogeneous soft-tissue attenuation contrast-enhancing abdominal mass is detected at CT in an asymptomatic patient. Even though imaging may be suggestive, a histological confirmation is still required for definitive diagnosis and to differentiate it from metastatic disease, lymphoproliferative disorders and other hyper vascularized masses. FINDINGS: Axial contrast enhanced CT of the pelvis in the parenchymal phase demonstrates a voluminous intra-peritoneal right pelvic solid mass (arrow). It is located behind right rectus abdominis muscle, medially respect right superficial femoral vessels and anterior to the uterus. The maximum diameter on the axial plane is of 4,7 cm. The lesion showed 113 HU of peak after contrast administration, displayed regular but lobulated margins and several calcification spots inside. The intraperitoneal location is recognizable due to the moderate upper-external dislocation of external iliac vascular pedicle. Uterine leiomyoma and a small amount of free fluid into the rectouterine pouch were also detected. Neither lytic bone lesions nor sclerotic bone lesions are detectable. TECHNIQUE: Axial CT, 156mAs, 100kV, 5,00 mm slice thickness, 80 ml Iodixanol 320 mgI/ml. 
